logically plausible candidate gene for type 2 diabetes (T2D). Discovery of restriction fragment length polymorphism (RFLP) in the GLUT4 gene [3] led to series of genetic association studies in the early 90s [4] [5] [6] [7] [8] [9] [10] . However, these results have so far been negative. On the other hand, the chromosome 17p13, where the GLUT4 resides has been shown to posses a linkage signal to metabolic syndrome [11] .
Recently, two independent studies in south Indian population revealed that SNP haplotypes of GLUT4 gene marginally associate with T2D [12, 13] . Therefore, in this study, we retrieved two SNPs, rs5418 and rs2654185, from the south Indian studies and determined their association with T2D prospective trait of HbA1c in a Japanese population.
Biosystems, Foster City, CA, USA). For each sample, 10_ng of purified DNA was mixed with 0.25_µL of 20x SNP genotyping assay mix containing forward and reverse primers, VIC & FAM probes, 2.5_µL of TaqMan universal PCR master mix and 2.25_µL of DNase -free water. PCR amplification was performed by in Thermal Cycler (Applied Biosystem 9700) with a holding temperature at 90 °C for 10_mins, 40 cycles of denaturation at 92 °C for 15 sec and annealing at 60 °C for 1 min, and finally followed by a cooling step at 4 °C. Following PCR, allelic discrimination was performed using a sequence detection system (ABI PRISM 7900HT, USA, SDS software package version 2.1.1) with a successful call rate of 99.98%.
Statistical analysis
LD structure of GLUT4 across a 20 kb region in JPT was inferred by HaploView determined from HapMap 2 data. Deviation of the genotype distribution from Hardy-Weinberg equilibrium was confirmed by chisquare test. Age, anthropometric measurements, and blood chemical data are shown as mean ± SD or mean. Comparisons of the numerical variables were assessed using an ANOVA test among genotypes in additive model and an independent sample t-test between genotypes in dominant model. Chi-square test was used to detect differences among the genotypes for categorical variables. Linear regression analysis was performed to analyze association of SNP rs5418 and rs2654185 alleles and genotypes with HbA1c level. All above calculations and statistical analyses were performed using SPSS for Windows software (version 19.0; SPSS Inc., Chicago, IL, USA). Haplotypes were inferred using Haplo Stats (R2.14.0). A mean value of each trait for each haplotype was estimated by Haplo Trend Regression (HTR) program and the corresponding significance value for association between the haplotype and trait was deduced by haplo.score program. P-values < 0.05 were considered statistically significant. Bonferroni correction was performed for multiple testing in case of comparison of each SNP. Power analysis was performed using GPower 3.1.3 [16] .
Results
The allele, genotype, and haplotype distributions of GLUT4 rs5418 and rs2654185 are shown in Table 1 . No significant deviation from Hardy-Weinberg equilibrium was observed for both loci. Four allelic happational cohorts, which were organized to investigate the association of lifestyle and genetic factors as well as their interaction with phenotypes of metabolic syndrome. This study was based on health check up and employees of a company were recruited. Those who gave a written informed consent were included in the study. The first and second cohorts comprise 360 and 431 Japanese manual workers working for a company in Kanagawa and Kyoto prefectures, respectively. 13 unsuccessful genotyping samples were excluded. Only 734 male samples were accepted in this study due to extremely small sample number of female (44) and to avoid sex effecting on HbA1c level. 82 and 25 cases were under medication of anti-hypertension and antihyperlipoidemia by oral medicine. Height and weight were measured, and Body Mass Index (BMI) was calculated as weight in kilogram divided by square of height in meter. Waist circumference was measured in the standing position midway between the iliac crest and the lower costal margin. Serum total cholesterol, triglyceride and HDL-cholesterol were analyzed using enzymatic colorimetric methods. Blood pressure was measured using a posterior wall velocity/ankle-brachial index (PWV/ABI) device (Nippon Colin, Aichi, Japan), after individuals rested quietly for at least 10 minutes in a supine position. Blood pressure was measured twice and the average mean value was recorded. Daily energy intake was calculated by a Food Frequency Questionnaire [14] . Hemoglobin A1c (HbA1c) was examined and the HbA1c result was calculated as a ratio to total hemoglobin by using a chromatogram. The HbA1c value was determined by Japan Diabetes Society (JDS) method which is 0.4% lower than National Glycohemoglobin Standardization Program (NGSP) value [15] . HbA1c ≥ 5.6% or 6.1% was used as criteria for possible and probable diabetes according to Japan National Diabetes Survey. The study was approved by the ethics review committee of the Medical Research Institute, Tokyo Medical and Dental University, and by other related agencies. Written informed consent was obtained from all participants.
Genotyping
A peripheral blood specimen was collected from each participant, and genomic DNA was extracted by conventional method. Genotyping for GLUT4 rs5418 and rs2654185 polymorphisms was performed by PCR using the TaqMan genotyping assay followed by allelic discrimination analysis using SDS software (Applied lotypes of GLUT4 were estimated. The most frequent haplotype GA (62.2%) and the second frequent one AC (30.0%) are the major haplotypes of all with a total percentage more than 90%. LD structure of the 20-kb region encompassing the GLUT4 gene is shown in Fig. 1 . This map was constructed on the bases of the data from HapMap2 of Japanese population. The SNP rs5418 and rs2654185 are 2 kb apart and are in linkage disequilibrium (r 2 = 0.67). Biochemical and life style characteristics of the subjects according to SNP rs5418 and rs2654185 genotypes are shown in Tables 2 and 3 , respectively. With regard to genotypes of rs5418, HbA1c level was highest in GG genotype (5.2 % ± 0.9%), middle in AG genotype (5.2% ± 0.8%), and lowest in AA genotype group (4.9% ± 0.4%). The difference was statistically significant by ANOVA test (P = 0.030). Since AG and GG carriers showed a prominent difference in HbA1c level compared with AA carriers, we combined the former two genotypes and compared the parameters in the Frequencies of SNP rs5418/rs2654185 haplotypes were estimated using Haplo Stats software. ± 0.4%, P < 0.001), the significance still exists after Bonferroni correction. Other parameters did not show significant differences according to the rs2654185 genotypes. If we assume type I error probability (α) = 0.05, effect size (Cohen's d) of detecting the difference of HbA1c of 5.2 (0.9SD) and 4.9 (0.4SD) = 0.4, the power of our sample (sample size = 734) computed by GPower program is 0.96. Since the basic analysis showed an obvious correlation between genotypes of the two SNPs and HbA1c level, we further carried out linear regression analysis. Results were shown in Table 4 . G allele and AG + GG genotype of rs5418 showed a significant association with higher HbA1c (β = 0.215, P = 0.026 and β = 0.215, P = 0.026 respectively). A allele and AA + AC genotype of rs2654185 showed a significant association with higher HbA1c (β = 0.190, P = 0.042 and β = 0.190, P = 0.042 respectively).
Then we analyzed the association of four allelic haplotypes of GLUT4 with multiple quantitative traits related for metabolism. The data for the haplotype association are shown in Table 5 . We showed significant values for each haplotype obtained by its dominant model, we also did analysis using additive and recessive models (data are not shown). We found GA haplotype has significantly higher HbA1c level after adjustment by age, BMI, energy intake, smoking and drinking habits (5.2%, P = 0.004). AC haplotype correlates to higher blood pressure and AA haplotype has lower HDL level than others. No significant association with the metabolic traits was found for the other haplotypes. rs5418 dominant model. HbA1c level is significantly higher in AG + GG genotype group than in AA genotype (P < 0.001), the association remains statistically significant even after correction for multiple testing by Bonferroni correction. Proportion of HbA1c≥5.6% is marginally higher in AG + GG group (P = 0.049), but the significance disappears after Bonferroni correction. There were no significant differences in terms of age, BMI, waist, serum lipid and blood pressure and life style factors according to the rs5418 genotypes.
With regard to the genotype of rs2654185, similarly, HbA1c level is significantly different according to the additive model (P = 0.042). In the AA + AC dominant model, HbA1c is significantly higher in AA + AC carriers compared with CC carriers (5.2 % ± 0.9% vs. 4.9% The first allele is rs5418 and the second allele is rs2654185. The mean values for each trait across haplotypes were computed by the HTR program. The significant values were obtained from the program haplo.score by Haplo Stats software using haplotype dominant model. P values for total cholesterol, triglyceride, HDL-cholesterol, blood pressure and HbA1c were adjusted by age, BMI, energy intake, smoking and drinking habits. In bold are cases with P < 0.05. haplotype is not the highest among all haplotypes, this may due to the very low frequencies of AA (3.1%) and GC (2.3%) haplotypes. In vice versa, the AC haplotype derived from two non-risk alleles is associated with lower HbA1c level. To further investigate the potential mechanism, we searched related trans-factor binding site for the SNP rs2654185 (C/A), which locates in promoter region of GLUT4. We found that polymorphism A to C change led to an appearance of the transcription factor GATA-1 binding site in this locus. Since A allele is the risk allele for HbA1c in this cohort, the GATA-1 binding in this locus might have up-regulate the transcription of GLUT4 and facilitated the glucose uptake. The way how rs2654185 affects the expression of GLUT4 gene warrants further study. The present study showed that polymorphism in the diabetes candidate gene -GLUT4 is associated with elevated HbA1c level. HbA1c, is a glycated hemoglobin, and is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose. The fraction of glycated hemoglobin increases in a predictable way. This serves as a marker for average blood glucose levels, 6 -8 weeks prior to HbA1c measurement. Therefore, HbA1c is widely accepted as a standard method for determining long -term glycemic control in diabetic patients [17] . HbA1c has been viewed as an independent criteria for diagnosing diabetes with a threshold of ≥6.5% according to American Diabetes Association 2010 guideline [18] . Japan National Diabetes Survey suggested HbA1c≥5.6% or 6.1% used as criteria for possible and probable diabetes. Recent studies in a European cohort have demonstrated that HbA1c is also an independent predictor of cardiovascular (CV) disease mortality even at concentrations below the accepted threshold for diabetes [19] . They showed people with HbA1c concentrations 5.0% -5.4% had the relative risk of death which were 1.41, 2.53 and 2.74 from all-cause, CV and ischemic heart disease respectively compared to those with HbA1c concentrations <5.0%. Although HbA1c level in the risk genotype group in our cohort is still within the normal range (5.2% (SD, 0.8)), these people may have relatively higher mortality risk for possible microvascular events. In the above-mentioned study, they also estimated 12% of the excess deaths could potentially be prevented by lowering the population mean HbA1c concentration by 0.1%, and 25% could be prevented by lowering the population mean by 0.2%. Two other studies have also validated that HbA1c is a progres-
Discussion
In this study, we found that two SNPs, rs5418 and rs2654185, of the GLUT4 gene are significantly associated with HbA1c in apparently healthy Japanese men. For rs5418 presented in 5' -UTR region, AG + GG dominant model is significantly associated with higher HbA1c level, G allele is the risk allele. For rs2654185 locating in promoter region, AA + AC genotype group correlates to higher HbA1c level, A allele is the risk allele. Since the two SNPs rs5418 and rs2654185 are in linkage disequilibrium, we carried out haplotype analysis. GA haplotype associates with higher HbA1c level and AC haplotype correlates to lower HbA1c level. To our knowledge, this is the first study indicating GLUT4 gene association with glycemic traits of HbA1c in any ethnic populations.
GLUT4 locus has been studied as a biologically plausible candidate gene for T2D, but the association studies have so far been negative. A study in Welsh population identified a silent polymorphism (Asn130) in exon 4 present in diabetic subjects. They also identified a Val383Ile mutation in exon 9 present in 3 out of 160 type 2 diabetes subjects but absent in the 80 control subjects [6] . These two mutations were later confirmed in diabetic patients in an Indian population [4] . But further analysis in British population did not suggest any association of these mutations with T2D [5] . Other studies on GLUT4 include KpnI RFLP studies in Italian, Caucasians, Chinese, and Asian Indians, American black and Japanese population which did not establish association between the KpnI RFLP and T2D [7, 9] . A recent study in a south Indian population examined four SNPs of GLUT4 gene in promoter and coding regions, including the target SNPs rs5418 and rs2654185 in our study. None of the selected SNPs in GLUT4 showed any significant association with T2D in their study, but haplotype analysis revealed that the haplotype AGGG (defined by SNPs rs2654185, rs5412, rs5418, rs5435) is marginally associated with T2D (P = 0.04) [12] . Another independent study in south Indians found the proportion haplotype ACGT in order of rs5418, rs5435, rs5421, and the T→G 3′UTR variant is significantly higher in normal subjects (7.5%) than in diabetes (5%, P = 0.003) [13] . Our result was consistent with these haplotypes that GA haplotype (in order of rs5418, rs2654185) combined with two risk alleles for each SNP in our cohort is associated with higher diabetic parameter HbA1c. Although HbA1c in GA sample size may influence our statistical power or decrease the precision. A larger sample number or a dependent replication study would be needed in our future study. Another imperfection in this study is that only HbA1c is available to indicate the glucose level. Other parameters like fasting blood-glucose, 2h-blood glucose or HOMA-B, HOMAR-IR would be included to fully evaluate the blood glucose level and insulin response.
In conclusion, we found that variants in GLUT4 gene are associated with HbA1c level in apparently healthy Japanese men. GLUT4 variation warrants further study with regard to glycemic control. sive risk factor for CV disease in individuals with and without diabetes [20, 21] . In our study, the current effect of GLUT4 variants on HbA1c is modest (rs5418 AG + GG vs. A A: 5.2% (SD, 0.8) vs. 4.9% (SD, 0.4), rs2654185 AA + AC vs. CC: 5.2% (SD, 0.9) vs. 4.9% (SD, 0.4), GA haplotype vs. others: 5.2% vs. 5.1%), we think that this difference should be considered for its possible connection with microvascular complications. The risk genotype and/or haplotype carriers having higher HbA1c concentrations would pay more attention to their nutrition and physical activity which are also important determinants of diabetes and glycemia in populations [22, 23] .
There are some limitations to our study. The small
